Though potentially successful, peginterferon and ribavirin are known to cause various side-effects in HCV patients. Most individuals suffer from some side-effects such as flu-like symptoms, myalgia, fatigue, gastrointestinal disturbances, psychiatric disorders, and hematological abnormalities such as anemia and leukopenia [3] [4] [5] .